Targeted therapies for the treatment of soft tissue sarcoma
Soft tissue sarcomas are rare malignant tumors derived from mesenchymal cells that have a high morbidity and mortality related to frequent occurrence of advanced and metastatic disease. Over the past two decades there have been significant advances in the use of targeted therapies for the treatment...
Main Authors: | Jeffrey W. Fuchs, Brian C. Schulte, Joseph R. Fuchs, Mark Agulnik |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1122508/full |
Similar Items
-
Emerging targeted and cellular therapies in the treatment of advanced and metastatic synovial sarcoma
by: Joseph R. Fuchs, et al.
Published: (2023-01-01) -
The Molecular Biology of Soft Tissue Sarcomas: Current Knowledge and Future Perspectives
by: Julien Vibert, et al.
Published: (2022-05-01) -
Experimental models of tumor growth in soft tissue sarcomas
by: Mariia S. Tretyakova, et al.
Published: (2023-12-01) -
Effective palliative treatment of recurrent soft tissue sarcoma in a dog using imatinib mesylate (Gleevec®)
by: G.H. Kim, et al.
Published: (2018-11-01) -
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma
by: Natalie K. Heater, et al.
Published: (2023-03-01)